Mefloquine induces cell death in prostate cancer cells and provides a potential novel treatment strategy in vivo

Kun Huang Yan, Yung Wei Lin, Chi Hao Hsiao, Yu-Ching Wen, Ke Hsun Lin, Chung Chi Liu, Mao-Chih Hsieh, Chih Jung Yao, Ming De Yan, Gi Ming Lai, Shuang En Chuang, Liang Ming Lee

研究成果: 雜誌貢獻文章同行評審

27 引文 斯高帕斯(Scopus)

摘要

Mefloquine (MQ) is currently in clinical use as a prophylactic treatment for malaria. Previous studies have shown that MQ induces oxidative stress in vitro. The present study investigated the anticancer effects of MQ treatment in PC3 cells. The cell viability was evaluated using sulphorhodamine-B (SRB) staining, while annexin V and propidium iodide (PI) were used as an assay for cell death. Reactive oxygen species (ROS) formation was detected with 2',7'-dichlorofluorescein-diacetate (DCFH-DA), a sensitive intracellular probe, and the alteration of cellular status was defined by trypan blue staining. The results of the present study indicated that MQ has a high cytotoxicity that causes cell death in PC3 cells. MQ markedly inhibited the PC3 cells through nonapoptotic cell death. MQ also induced significant ROS production. The MQ treatment mediated G1 cell cycle arrest and cyclin D1 accumulation through p21 upregulation in the PC3 cells. Moreover, the use of MQ improved the survival of the treatment group compared with the control group in the experimental mice. The present study indicates that MQ possesses potential therapeutic efficacy for the treatment of prostate cancer (PCa) in vivo. These findings provide insights that may aid the further optimization and application of new and existing therapeutic options.
原文英語
頁(從 - 到)1567-1571
頁數5
期刊Oncology Letters
5
發行號5
DOIs
出版狀態已發佈 - 10月 2013

ASJC Scopus subject areas

  • 腫瘤科
  • 癌症研究

指紋

深入研究「Mefloquine induces cell death in prostate cancer cells and provides a potential novel treatment strategy in vivo」主題。共同形成了獨特的指紋。

引用此